VRAX icon

Virax Biolabs

5 hedge funds and large institutions have $424K invested in Virax Biolabs in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$282K +$261K +134,399 +1,222%
Squarepoint
2
Squarepoint
New York
$78.8K +$78.8K +40,620 New
UBS Group
3
UBS Group
Switzerland
$39.8K +$29K +14,929 +267%
Jane Street
4
Jane Street
New York
$22.6K +$22.6K +11,635 New
HT
5
Headlands Technologies
Illinois
$359 +$272 +140 +311%
VF
6
Virtu Financial
New York
-$33K -28,058 Closed
HF
7
HRT Financial
New York
-$29K -25,672 Closed
Qube Research & Technologies (QRT)
8
Qube Research & Technologies (QRT)
United Kingdom
-$348 -300 Closed
Wells Fargo
9
Wells Fargo
California
-$116 -100 Closed